Our Firm has received frequent inquiries from women who allegedly experienced the spread of dangerous cancers due to uterine morcellation.
New York, New York (PRWEB) November 06, 2014
As concerns mount over the safety of surgical tools called power morcellators (http://www.morcellatorlawsuit2015.com/) , Bernstein Liebhard notes that three tragic deaths that occurred in Rochester, New York over the past year have helped fuel the controversy currently surrounding the devices. According to the Rochester Democrat & Chronicle, all three cases involved women who had undergone uterine morcellation to remove what had been thought to be benign fibroids, but actually turned out to be uterine cancers. As the report notes, federal health regulators recently warned that using a power morcellator in gynecological surgeries may promote the dissemination of undetected uterine sarcomas and other cancers.*
“Our Firm has received frequent inquiries from women who allegedly experienced the spread of dangerous cancers due to uterine morcellation. What reportedly happened to the three women in Rochester only serves to highlight the potential risks associated with power morcellators,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now evaluating potential morcellator lawsuits on behalf of women who may have experienced the spread of undiagnosed uterine sarcoma and other cancers due to uterine morcellation.
Uterine Morcellation and Cancer
Power morcellators are used in laparoscopic hysterectomies and fibroid removals to shred tissue so that it can be easily removed through a small incision in the abdomen. In April, the U.S. Food & Drug Administration (FDA) warned that use of the devices in gynecological procedures could spread undetected uterine cancer cells throughout a woman’s body. The FDA stated that roughly 1 in 350 women with fibroids actually have undiagnosed uterine sarcoma, which is not easily detected via currently available screening methods. Dissemination of those cancer cells outside of the uterus can greatly reduce a woman’s chances for long-term survival.
Since the FDA issued that alert, calls for a ban on power morcellators have grown. However, the agency recently indicated that it has no plans to take such action at this time.** In July, Johnson & Johnson’s Ethicon, Inc. unit did withdraw three of its morcellators from the market because of the uncertainty surrounding their safety.***
Court records also indicate that a growing number of power morcellator lawsuits have been filed in U.S. courts on behalf of women who allegedly experienced the spread of uterine cancers due to the devices. Just last month, one such case was filed in the U.S. District Court for the Eastern District of California on behalf of a woman who allegedly developed seven cancerous tumors in her abdomen after undergoing uterine morcellation to remove fibroids. (Nielsen, et ux. v. Gyrus Acmi LLC, No. 2:14-2375)
Women who allegedly experienced the spread of uterine sarcoma or other cancer due to a power morcellator may be entitled to file a legal claim against the manufacturer of the device used in their surgery. To learn more about the process for filing a morcellator lawsuit, please visit Bernstein Liebhard LLPs website, or call the Firm directly for a free, no-obligation case review at 800-511-5092.
- democratandchronicle.com/story/all-about-health/2014/11/03/fda-has-the-opportunity-to-be-righteous/18408089/, November 3, 2014
**democratandchronicle.com/story/news/2014/10/09/power-morcellation-fibroid-gillibrand-schumer/16975935/, Rochester Democrat and Chronicle, October 10, 2014
***ethicon.com/sites/default/files/managed-documents/Ethicon%20Morcellation%20Devices%20Customer%20Letter%20Final.pdf, Ethicon, Inc., July 30, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP